Desktop Genetics & Transcriptic Collaborate to Reduce Complexity, Costs, and Time Involved in CRISPR/Cas9 Gene Editing; Partnership Intended to Provide Seamless On-Demand CRISPR/Cas9 Gene Editing; Mark Cuban Among Transcriptic Investors

In a November 5, 2015 announcement, Desktop Genetics Ltd. (DTG), a London-based software company focused on revolutionizing the way biologists use CRISPR/Cas9 gene editing technology, stated that it has signed a partnership agreement with Transcriptic, Inc., a California-based robotic cloud laboratory for life sciences. The partnership, announced at the SynBioBeta San Francisco 2015 Conference (November 4-6) (, will combine DTG’s CRISPR/Cas9 design software with Transcriptic’s services for cloud-based, high-throughput cloning of CRISPR constructs, to provide customers with seamless, on-demand CRISPR gene editing. From today (November 5, 2015), DTG announced, researchers in industry and academia will be able to benefit from access to the integrated offering that aims to eliminate time-intensive manual steps involved in the gene-editing process to reduce the complexity, costs, and time required to modify any gene in any organism or cell line. Under terms of the agreement, DTG will provide proprietary, high-performance CRISPR library design algorithms from the DESKGEN gene-editing platform, while Transcriptic will conduct the automated, high-throughput assembly of the CRISPR libraries using their self-contained robotic molecular biology labs, known as Workcells. Through a simple web browser interface, customers will have full input on experimental design parameters and will effectively eliminate several time-intensive manual steps involved in the gene editing process.
Login Or Register To Read Full Story